Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 10.2218 | 98 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 10.2914 | 98 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 9.98896 | 98 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 10.2793 | 98 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 10.4036 | 98 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 10.0572 | 98 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 10.2398 | 98 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 10.273 | 98 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 10.1436 | 98 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 10.3074 | 98 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 10.5053 | 98 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 10.2787 | 98 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 10.5833 | 98 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 10.4209 | 98 |